UCSF, Optivia Get $430K Grant for ADME Tool Development | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of California, San Francisco, and Optivia Biotechnology today said that they have received a $430,000 Phase I Small Business Innovation Research grant to develop a system for characterizing the role transporter proteins play in the disposition of drugs by the liver.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.